Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial
- DOI
- 10.2147/opth.s392315
- Published
- 2022-12
- Container
- Clinical Ophthalmology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/opth.s392315,
title = {Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial},
author = {Barry A Schechter and Maitee Urbieta and Jason Bacharach and Melissa Toyos and Robert Smyth-Medina and Brittany Mitchell and Jodi I Luchs},
year = {2022},
journal = {Clinical Ophthalmology},
doi = {10.2147/opth.s392315},
url = {https://doi.org/10.2147/opth.s392315}
}RIS
TY - JOUR TI - Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial AU - Barry A Schechter AU - Maitee Urbieta AU - Jason Bacharach AU - Melissa Toyos AU - Robert Smyth-Medina AU - Brittany Mitchell AU - Jodi I Luchs PY - 2022 JO - Clinical Ophthalmology DO - 10.2147/opth.s392315 UR - https://doi.org/10.2147/opth.s392315 ER -
APA
Schechter, B. A., Urbieta, M., Bacharach, J., Toyos, M., Smyth-Medina, R., Mitchell, B., & Luchs, J. I. (2022). Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial. Clinical Ophthalmology. https://doi.org/10.2147/opth.s392315
Source records
- crossref · retrieved 2026-09-26T18:15:10.276Z